Investigation of the effect of Iscador drug on patients with sarcoma
Phase 4
Recruiting
- Conditions
- Condition 1: Sarcoma of bone and articular cartilage of limbs. Condition 2: Sarcoma of bone and articular cartilage of other and unspecified sites. Condition 3: Sarcoma of other connective and soft tissue.Malignant neoplasm of bone and articular cartilage of limbsMalignant neoplasm of bone and articular cartilage of other and unspecified sitesMalignant neoplasm of other connective and soft tissue
- Registration Number
- IRCT20240121060752N1
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 74
Inclusion Criteria
Patients with written consent
Patients with soft tissue and bone sarcomas in different parts of the body, such as limbs, trunk, and head, who have indications for surgery
Patients aged between 10 and 70 years
Exclusion Criteria
Patients who have not followed up or visited after surgery
Those were already treated with Iscador's drug
Pregnant and lactating people
People unable to respond to the quality of life scale
Concomitant treatment with steroids
People who are allergic to medicines
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method